100 High Street
Buffalo, NY 14203
Diabetes Center is Awarded by American Diabetes Association
While the DiabetesCenter has been accredited by the National Committee of Quality Assurance (NCQA), thereby providing a reliable indicator that our center is well-managed and delivers high quality care and service, there are new requirements for top centers to also be accredited by the ADA.
With its award, the ADA recognizes the DiabetesCenter at Women & Children’s Hospital of Buffalo for meeting the national standards for diabetes self-management education and expressed its confidence in our center’s effort, commitment and success in providing quality diabetes education.
This project was spearheaded by Dr. Indrajit Majumdar and made possible by our entire diabetes team, including the researchers who supplement our clinical providers and interact with patients on a daily basis.
The DiabetesCenter operates as a partnership between UBMD Pediatrics and Women & Children’s Hospital of Buffalo. The Center plays a key role in the Western New York community where over 900 children with Type 1 and Type 2 diabetes receive care. Although commonly thought of as an adult disease, Type 2 diabetes is now being diagnosed in children due in large part to the epidemic of childhood obesity.
The Center is the only pediatric hospital to have received the designation of the Diabetes Center of Excellence for Type 2 diabetes from the New York State Department of Health with a grant awarded between 2006 – 2011; followed by a New York State grant awarded in 2011 for Obesity Prevention.
The Division of Endocrinology/Diabetes is part of UBMD Pediatrics and is affiliated with the School of Medicine and Biomedical Sciences at the University at Buffalo. It provides comprehensive care to infants, children and young adults affected by diabetes or hormonal (endocrine) disorders. These include, but are not limited to: short stature, overweight, thyroid and adrenal conditions, disorders of pubertal development and sexual differentiation, bone health and disorders of calcium metabolism. The Division's mission is to deliver the best care to children with diabetes and endocrine disorders in Western New York and beyond, while bringing to them the latest in research development.
The DiabetesCenter is also a participant in TrialNet, an international study funded by multiple sources including the National Institutes of Health, whose main focus is to develop interventions that will prevent, delay and reverse the progression of Type 1 diabetes. For more information on TrialNet, please click on the following link: http://www.buffalo.edu/news/releases/2013/05/002.html
|Related Kaleida Service: Endocrinology/Diabetes|